D. E. Shaw & Co., Inc. Organon & Co. Call Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $165,900 - $237,700	10,000 New	10,000 $173,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $609 - $787	-20 Reduced 0.28%	7,000 $245,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $199,719 - $266,760	7,020 New	7,020 $212,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.93B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.